Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Understanding the Differences Between Spravato and Ketamine: A Comprehensive Guide

Murray, UT (Newsworthy.ai) Wednesday Apr 26, 2023 @ 4:00 AM Central —

The pharmaceutical industry has seen recent innovations in treating depression, notably with the emergence of Spravato (esketamine).

Spravato is the S-enantiomer form of ketamine, a racemic mixture of two enantiomers. As for their administration, Spravato is an intranasal formulation, meaning it is administered through the nose, while ketamine can be administered intravenously, intramuscularly, or orally. Additionally, Spravato has obtained FDA approval for treatment-resistant depression. In contrast, ketamine has yet to secure this status and has been widely used off-label for depression and other mental health conditions.

Other differences between Spravato and ketamine include dosage and monitoring requirements. The dose of Spravato used in treatment is lower than ketamine, which may result in fewer side effects for some patients. However, Spravato must be administered in a clinical setting, with patients monitored for at least two hours post-treatment. On the other hand, ketamine can be administered in both clinical and non-clinical settings.

Lone Peak Psychiatry considers that the launch of Spravato has significantly addressed the unmet needs of depression management. Industry professionals are optimistic that it will revolutionize care for those with treatment-resistant depression. Its unique administration style, dosage options, and FDA-approved status amplify this hope.

About Lone Peak Psychiatry

Lone Peak Psychiatry is a Ketamine clinic located in Murray, UT. We offer Ketamine treatments to those suffering from Mental Health disorders such as Depression, Anxiety, PTSD, and OCD. Our mission is to help those struggling to find relief and regain their lives.


This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.